Pricing Log in Create free account

Achieve Life Sciences, Inc. (ACHV) vs Immix Biopharma, Inc. (IMMX)

Achieve Life Sciences, Inc. and Immix Biopharma, Inc. are both Biotechnology companies. Achieve Life Sciences, Inc. and Immix Biopharma, Inc. are of similar size ($719.6M and $717.2M). Across the 8 metrics below, Immix Biopharma, Inc. leads on 5 and Achieve Life Sciences, Inc. on 3.

Valuation

Metric ACHV IMMX Biotechnology median
P/E n/m n/m 8.50
P/S 38.00 n/m 9.71
P/B n/m 2.22 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 27.19 n/m 9.21
Earnings yield (24.11%) (11.03%) (33.15%)
Free cash flow yield (7.83%) (7.68%) (25.50%)

Profitability

Metric ACHV IMMX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (844.99%) (34.18%) (56.36%)
Return on assets (91.46%) (31.34%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACHV IMMX Biotechnology median
Revenue growth (TTM) (5.58%) — 6.02%
EPS growth (last fiscal year) (0.81%) (17.11%) 30.26%
Revenue growth, 5-year CAGR (17.95%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACHV IMMX Biotechnology median
Debt to equity (1.11) 0.00 0.00
Current ratio 0.95 25.13 4.72
Net debt to EBITDA 0.36 3.39 0.96

Dividend

Metric ACHV IMMX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACHV IMMX Biotechnology median
Market cap 717.23m 719.59m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack